| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/25/2008 | US20080234469 Binding to monoclonal antibodies; antitumor agents |
| 09/25/2008 | US20080234385 Method For Inhibiting Tnf-Alpha |
| 09/25/2008 | US20080234311 IMMUNOASSAY FOR DETECTION AND QUANTIFICATION OF AMYLOID-beta PEPTIDES |
| 09/25/2008 | US20080234304 N3-Pyridyl-Thiamine And Its Use In Cancer Treatments |
| 09/25/2008 | US20080234223 5-azacytidine pyrimidine analog is epigenetic agent histone deacetylase inhibitor; inhibits nucleic acid methylation through an N4 carboxylester or ester bond; acetylcholine cell-targeting agent; cell expresses acetylcholinesterase; central nervous system; liver cancer |
| 09/25/2008 | US20080234219 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 09/25/2008 | US20080234211 Decladinosyl-Macrolides With Anti-Inflammatory Activity |
| 09/25/2008 | US20080234201 BH3 peptides and method of use thereof |
| 09/25/2008 | US20080234176 Modified peptides and their uses |
| 09/25/2008 | US20080233650 Tetracycline operon repressor protein transfection; replication-deficient; veterinary medicine |
| 09/25/2008 | US20080233649 Progenitor cells; serum-free; differentiation; cloning |
| 09/25/2008 | US20080233648 Biasing of cells toward retinal, corneal or lens development |
| 09/25/2008 | US20080233647 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase |
| 09/25/2008 | US20080233646 Human DR4 antibodies and uses thereof |
| 09/25/2008 | US20080233645 Methods and Compositions of Ig20 and Denn-Sv Splice Variants |
| 09/25/2008 | US20080233644 Chimeric Transcription Factor Decoy Oligonucleotides |
| 09/25/2008 | US20080233643 Coculturing CD34+ cells from umbilical cord blood with an immortalized stromal cells in the presence of a cytokine to prepare hematopoietic progenitor cells which differentiate into megakaryocytic lineage cells after removal of stromal cell; proliferation up to the 100,000-fold level; industrial scale |
| 09/25/2008 | US20080233642 Mammalian immortalized liver cell |
| 09/25/2008 | US20080233641 Nucleotide sequences coding zinc finger proteins which control genes associated with tocopherol biosynthesis; bioreactors; foods and antioxidants |
| 09/25/2008 | US20080233640 Prostate cancer; CD133 antigen, alpha 2 beta 1 integrin, human epithelial antigen and CD44 antigen |
| 09/25/2008 | US20080233639 Fusion protein delivery system and uses thereof |
| 09/25/2008 | US20080233638 Nucleotide sequences coding regulatory proteins comprising death domains for identifying modulators of nuclear factor kappa beta activity and treatments for cell proliferative and neurodegenerative diseases; gene expression inhibition |
| 09/25/2008 | US20080233637 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 09/25/2008 | US20080233635 particle differentiation device; identifying and separating sperm cells according to chromosomal complement; photomultiplier tube converts light from light emission source into one differentiation signal; cattle, sheep, and/or horse in vitro fertilization and veterinary medicine |
| 09/25/2008 | US20080233629 Fusion protein for use in genration of preferential biopolymers in plants |
| 09/25/2008 | US20080233623 Genetically modified host cells for increased p450 activity levels and methods of use thereof |
| 09/25/2008 | US20080233611 pairs of orthogonal-tRNAs (O-tRNAs) and orthogonal aminoacyl-tRNA synthetases (O RSs) that do not interact with the host cell translation machinery |
| 09/25/2008 | US20080233610 by administering at least one or a plurality of potency-determining factors; not c-Myc and Klf4; at least one putative potency-determining factor is Oct-4, Sox2 and at least one of Nanog and Lin28 |
| 09/25/2008 | US20080233607 for the functional maintenance of cells, particularly anchorage-dependent cells; for the long term culture of hepatocytes in vitro |
| 09/25/2008 | US20080233598 Active and/or passive immunization; accurate early stage, localized tumor detection |
| 09/25/2008 | US20080233596 Chimeric human t1r1 taste receptor polypeptides and compositions containing same |
| 09/25/2008 | US20080233584 chemically modified oligonucleotides; double stranded iRNA agent; comprising a cholesterol moiety; increased stability in a biological sample |
| 09/25/2008 | US20080233565 PKHDL1, a homolog of the autosomal recessive kidney disease gene |
| 09/25/2008 | US20080233560 DNA-transfection system for the generation of infectious influenza virus |
| 09/25/2008 | US20080233556 Cytotonic protein and utlization thereof |
| 09/25/2008 | US20080233221 Administering to subject an effective amount of xanthohumol or xanthoaurenol, xanthohumol analog, (e.g. a xanthohumol metabolite); xanthohumol exhibits antioxidant and free radical scavenging properties |
| 09/25/2008 | US20080233195 Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth |
| 09/25/2008 | US20080233166 A pressure/flow loop subsystem coupled to a controller: a specimen holder, an external flow loop system, and an output for outputting feedback information; producing hybrid vascular grafts that can yield implantable grafts that combine synthetic grafts with living cells |
| 09/25/2008 | US20080233164 Polymer for Use in Conduits, Medical Devices and Biomedical Surface Modification |
| 09/25/2008 | US20080233162 Bio-degradable aliphatic polyesters, polylactic acid, polyglycolic acid, poly(D,L-lactide-co-glycolide), poly(caprolactone), polyester-amide/polyester-urethane, poly(valerolactone), poly(hydroxyl butyrate) a poly(hydroxyl valerate) or chitosan, chitin, alginic acid, collagen, gelatin or hyaluronic acid |
| 09/25/2008 | US20080233148 Method of Producing Virus |
| 09/25/2008 | US20080233147 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 09/25/2008 | US20080233140 Binding Dectin-1 on immune cells with anti-Dectin-1-specific antibodies; rAb proteins; antigen presentation and immune cell activation; vaccines |
| 09/25/2008 | US20080233139 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/25/2008 | US20080233132 Immunotherapy with myelin repair; immunoglobulins; autoimmune disorders |
| 09/25/2008 | US20080233124 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 09/25/2008 | US20080233123 Polypeptide from haemophilus influenzae |
| 09/25/2008 | US20080233122 Complementarity determining regions; immunoglobulins; cell line, host cells; transgenic animals, plants |
| 09/25/2008 | US20080233120 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 09/25/2008 | US20080233119 Modulating death receptor 3 and/or CD30 function; interleukin expression inhibition |
| 09/25/2008 | US20080233116 Human monoclonal antibodies to CTLA-4 |
| 09/25/2008 | US20080233114 Antibodies to fibroblast growth factor; fusion proteins; cardiovascular disorders |
| 09/25/2008 | US20080233111 DNAX interferon-like receptor polypeptides for generating atibodies for use in treatment and prevention of septic shock, inflammation, cell proliferative and viral infection |
| 09/25/2008 | US20080233107 Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide |
| 09/25/2008 | US20080233101 RNA-mediated epigenetic regulation of gene transcription |
| 09/25/2008 | US20080233100 Targeted enzymes |
| 09/25/2008 | US20080233095 Method for obtaining antigen-specific tr1 regulatory lymphocytes |
| 09/25/2008 | US20080233089 Modified Cells Expressing a Protein That Modulates Activity of Bhlh Proteins, and Uses Thereof |
| 09/25/2008 | US20080233087 Methods for identifying, isolating, and utilizing endocrine progenitor cells from adult human pancreata |
| 09/25/2008 | US20080233046 Antisense agents; RNA interference; gene expression inhibition; hybridomas; hormone replacement therapy |
| 09/25/2008 | US20080230399 Fructosylamine Oxidase |
| 09/25/2008 | CA2681193A1 Pericycle-specific expression of microrna167 in transgenic plants |
| 09/25/2008 | CA2658508A1 Method of protecting against staphylococcal infection |
| 09/24/2008 | EP1972935A1 Screening method for infectious agent of prion disease |
| 09/24/2008 | EP1972686A1 Crystal structure of dicamba monooxygenase (DMO) and uses thereof |
| 09/24/2008 | EP1972685A1 Culture medium for gingival fibroblasts |
| 09/24/2008 | EP1972684A1 Medium for culturing autologous human progenitor stem cells and applications |
| 09/24/2008 | EP1972640A1 Apoptosis inducing antibodies |
| 09/24/2008 | EP1972635A1 Compounds and methods for lowering cholesterol levels without inducing hypertriglyceridemia |
| 09/24/2008 | EP1972194A1 Transgenic mammals having human ig loci including plural vh and vk regions and antibodies produced therefrom |
| 09/24/2008 | EP1971687A2 Dsrna as insect control agent |
| 09/24/2008 | EP1971683A2 Adenylate cyclase, gene sequence coding for adenylate cyclase, vectors and cells, and the use thereof |
| 09/24/2008 | EP1971681A1 Compositions and methods for inhibiting adverse immune response in histocompatibility-mismatched transplantation |
| 09/24/2008 | EP1971680A1 Method for generating dendritic cells employing decreased temperature |
| 09/24/2008 | EP1971679A2 Mesenchymal stem cells expressing tnf- receptor |
| 09/24/2008 | EP1971367A2 Methods and compositions for needleless delivery of binding partners |
| 09/24/2008 | EP1759536A4 In vitro techniques for use with stem cells |
| 09/24/2008 | EP1521771B1 STREPTOCOCCUS PNEUMONIAE PBP2x MINI-PROTEIN AND USES THEREOF. |
| 09/24/2008 | EP1385544B1 Humanized antibodies |
| 09/24/2008 | EP1352068B1 Bacillus thuringiensis insecticidal proteins |
| 09/24/2008 | EP1261705B1 Methods and compositions for screening using diphtheria toxin constructs |
| 09/24/2008 | EP1084239B1 Polymorphic markers of prostate carcinoma tumor antigen-1 (pcta-1) |
| 09/24/2008 | EP1029046B1 Wnt-1 inducible genes |
| 09/24/2008 | EP0979272B1 Strl33, a human fusion accessory factor associated with hiv infection |
| 09/24/2008 | CN101273124A 干细胞融合癌发生模型 Stem cell fusion model of carcinogenesis |
| 09/24/2008 | CN101273123A Cell/ligand marking system, wherein the marker is of Eph type, cell material comprising said system, method for preparing same and proangiogenetic use |
| 09/24/2008 | CN101273122A Use of common gamma chain cytokines for the genetic modification of memory T lymphocytes |
| 09/24/2008 | CN101273121A Improved methods and compositions for increasing longevity and protein yield from a cell culture |
| 09/24/2008 | CN101273064A Anti-TrkB monoclonal antibodies and uses thereof |
| 09/24/2008 | CN101272804A Modulation of granulosa cell apoptosis |
| 09/24/2008 | CN101272690A Secretory cell-containing macrobeads comprising seakem gold agarose, and uses thereof |
| 09/24/2008 | CN101272681A High oleic imidazolinone resistant sunflower |
| 09/24/2008 | CN101270366A Method for improving transgenic insect cell expression exogenous gene level |
| 09/24/2008 | CN101270362A Novel serine protease genes related to DPPIV |
| 09/24/2008 | CN101270361A Japanese blood fluke TSP protein extracellular cyclo-2 encoding gene, polypeptide, amalgamation protein and uses in preparing vaccine |
| 09/24/2008 | CN101270360A XAGE-1 gene and application of its expression production in tumour treatment and diagnosis |
| 09/24/2008 | CN101270353A Method for quickly acquiring transgenic sugarcane by using pmi gene |
| 09/24/2008 | CN101270349A Method for placenta mesenchyma stem cell separation and in vitro amplify cultivation |
| 09/24/2008 | CN101270348A Surface activity liquid of lung |
| 09/24/2008 | CN101270332A Apparatus and method for cultivation and process of cell or tissue |